glp 1 crohn's GLP-1 Use in Disease: Safety & IBD Considerations – PlexusDx GLP-1 and Gut Health: Addressing

After matching 168,428 patients in each group, GLP-1 receptor agonist users had a VTE rate of 11.0 per 1,000 patient-years compared to 12.9 per 1,000 patient-years in those taking DPP-4 inhibitors (a different class of diabetes medication)

Most weight lost is fat, but research suggest that about 20% of it is lost as lean muscle. Maintaining muscle is key to overall health and wellness

K., Nichols, L., Chen, Y., Lu, B

This approach with dual agonists has been followed by the development of monomeric triagonists, incorporating residues from GLP-1, glucagon and GIP

AOD9604 may support fat metabolism, but its not a standalone solution

a standard 35 grams daily approach takes longer to work but carries lower risk